Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
28 January 2025 - 8:01AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of
the Securities Exchange Act of 1934
For
the month of January 2025
Commission
File Number: 001-40614
INTERCURE
LTD.
(Translation
of registrant’s name into English)
85
Medinat ha-Yehudim Street
Herzliya,
4676670, Israel
Tel:
+972 77 460 5012
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
On
January 27, 2025, Intercure Ltd. (the “Company”) convened an extraordinary general meeting of shareholders (the “Extraordinary
General Meeting”). However, the Extraordinary General Meeting was adjourned for one week to the same day, time and place due to
lack of quorum. Accordingly, the Company’s Extraordinary General Meeting will be reconvened on Monday, February 3, 2025 at 4:00
p.m., Israel time, at the offices of the Company’s attorneys, Doron Tikotzky Kantor Gutman & Amit Gross, at 7 Metsada St.,
B.S.R Tower 4, Bnei Brak, Israel.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| |
INTERCURE
LTD. |
| |
|
| Date:
January 27, 2025 |
/s/
Amos Cohen |
| |
Amos
Cohen
Chief
Financial Officer |
Intercure (NASDAQ:INCR)
Historical Stock Chart
From Feb 2025 to Mar 2025
Intercure (NASDAQ:INCR)
Historical Stock Chart
From Mar 2024 to Mar 2025
